Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterNo recent work listed

Sophie Poty

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5496-0758; OpenAlex author ID A5012628689. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 3

  1. Identification of new FK866 analogues with potent anticancer activity against pancreatic cancer. Co-author DOI 10.1016/j.ejmech.2022.114504↗
  2. 89Zr-PET imaging of DNA double-strand breaks for the early monitoring of response following α- and β-particle radioimmunotherapy in a mouse model of pancreatic… Co-author DOI 10.7150/thno.44772↗
  3. Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-18-1650↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jason Stuart Lewis · 2 shared papers, 2019–2020 · strength 0.23
  2. James C. Knight · 1 shared paper, 2020 · strength 0.13
  3. Bart T. Cornelissen · 1 shared paper, 2020 · strength 0.13
  4. Alessio Nencioni · 1 shared paper, 2022 · strength 0.12
  5. Faustino Mollinedo · 1 shared paper, 2022 · strength 0.12
  6. Pierre Vogel · 1 shared paper, 2022 · strength 0.12
  7. Jian‐Fei Bai · 1 shared paper, 2022 · strength 0.12
  8. Consuelo Gajate · 1 shared paper, 2022 · strength 0.12
  9. Aimable Nahimana · 1 shared paper, 2022 · strength 0.12
  10. Brian Matthew Zeglis · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.